Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Uterine Cancer » Stats
 

Statistics about Uterine Cancer

Prevalence and incidence statistics for Uterine Cancer:

See also prevalence and incidence page for Uterine Cancer

Prevalance of Uterine Cancer: 4,500 women in the UK 2001 (National Statistics, UK Government Census, 2001)

Prevalance Rate: approx 1 in 13,333 or 0.01% or 20,400 people in USA [about data]

Lifetime risk for Uterine Cancer: 1 in 75 women will develop uterine cancer during their lifetime in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)

Incidence statistics about Uterine Cancer:

The following statistics relate to the incidence of Uterine Cancer:

  • 40,320 new cases for uterine cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 40,320 new female cases for uterine cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 3,800 new cases in women of uterine cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 19 per 100,000 new cases of uterine cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Incidence statistics by state in Australia:
    • 13.6 new female cases of uterine cancer occurred per 100,000 population in New South Wales 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 16.8 new female cases of uterine cancer occurred per 100,000 population in Victoria 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 15.4 new female cases of uterine cancer occurred per 100,000 population in Queensland 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 12.6 new female cases of uterine cancer occurred per 100,000 population in Western Australia 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 17.2 new female cases of uterine cancer occurred per 100,000 population in South Australia 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 12.7 new female cases of uterine cancer occurred per 100,000 population in Tasmania 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 16.3 new female cases of uterine cancer occurred per 100,000 population in Australian Capital Territory 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 16.4 new female cases of uterine cancer occurred per 100,000 population in Northern Territory 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • 1,654 new cases of uterine cancer occurs in women in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Uterine cancer accounted for 4% of all new cases of female cancer in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Uterine cancer accounted for 15.8 new female cases per 100,000 population in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • more about incidence...»

Death and mortality statistics for Uterine Cancer:

Deaths from Uterine Cancer: 6,468 deaths reported in USA 1999 (NVSR Sep 2001)

Death rate extrapolations for USA for Uterine Cancer: 6,468 per year, 539 per month, 124 per week, 17 per day, 0 per hour, 0 per minute, 0 per second. Note: this extrapolation calculation uses the deaths statistic: 6,468 deaths reported in USA 1999 (NVSR Sep 2001)

Death statistics for Uterine Cancer:

The following are statistics from various sources about deaths and Uterine Cancer:

  • 7,090 estimated deaths for uterine cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 7,090 estimated female deaths for uterine cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 3 per 100,000 deaths in women from uterine cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 700 deaths in women from uterine cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Mortality rate statistics for deaths from uterine cancer in various countries:
    • 2.0 women per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.6 women per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.8 women per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.2 women per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.8 women per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.4 women per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 0.4 women per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.5 women per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.9 women per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.0 women per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.4 women per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.4 women per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.9 women per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.5 women per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.1 women per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.1 women per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.1 women per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.1 women per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.5 women per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.8 women per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.2 women per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.4 women per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.9 women per 100,000 population per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.3 women per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.0 women per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 0.2 women per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.5 women per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.2 women per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.2 women per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.0 women per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.9 women per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.3 women per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.2 women per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.2 women per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.6 women per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.2 women per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.4 women per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.4 women per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 2.0 women per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.3 women per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.4 women per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 1.7 women per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.7 women per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
  • Uterine cancer caused 261 female deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Uterine cancer accounted for 1.7% of female cancer deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Uterine cancer accounted for 2.5 female deaths per 100,000 population in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • more about deaths...»

Survival rate statistics for Uterine Cancer:

The following are statistics from various sources about the survival rate for Uterine Cancer:

  • 86% of white people survive 5 years for uterine cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 60% of African American people survive 5 years for uterine cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 84% survive 5 years for uterine cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 83.2% of people with uterine corpus cancer survive after 5 years in the US 1983-90 (SEER)
  • 5-year survival rate for black women with corpus and uterus cancer is 55.2% in the US 1983-90 (SEER)
  • 5-year survival rate for white women with corpus and uterus cancer is 84.9% in the US 1983-90 (SEER)
  • 5-year survival rate for women with corpus and uterus cancer is 83.2% in the US 1983-90 (SEER)
  • 1-year survival rate for women aged 15-99 with uterine cancer is 85.2% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with uterine cancer is 70.6% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with uterine cancer is 90% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with uterine cancer is 81% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with uterine cancer is 93% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with uterine cancer is 85% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with uterine cancer is 93% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with uterine cancer is 83% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with uterine cancer is 89% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with uterine cancer is 74% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with uterine cancer is 81% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with uterine cancer is 63% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with uterine cancer is 64% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with uterine cancer is 44% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • more about deaths...»

Life Expectancy & Years of Life Lost for Uterine Cancer

Average life years lost for Uterine Cancer: 15.3 years for corpus/uterus NOS, not including cervix cancer (SEER)1

Society statistics for Uterine Cancer

Hospitalization statistics for Uterine Cancer:

The following are statistics from various sources about hospitalizations and Uterine Cancer:

  • 0.075% (9,544) of hospital consultant episodes were for malignant neoplasm of corpus uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 96% of hospital consultant episodes for malignant neoplasm of corpus uteri required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 100% of hospital consultant episodes for malignant neoplasm of corpus uteri were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 10% of hospital consultant episodes for malignant neoplasm of corpus uteri required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 7.3 days was the mean length of stay in hospitals for malignant neoplasm of corpus uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 5 days was the median length of stay in hospitals for malignant neoplasm of corpus uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 66 was the mean age of patients hospitalised for malignant neoplasm of corpus uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 29% of hospital consultant episodes for malignant neoplasm of corpus uteri occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 25% of hospital consultant episodes for malignant neoplasm of corpus uteri occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 22% of hospital consultant episodes for malignant neoplasm of corpus uteri were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.096% (50,120) of hospital bed days were for malignant neoplasm of corpus uteri in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.007% (869) of hospital consultant episodes were for benign neoplasm of uterus in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 99% of hospital consultant episodes for benign neoplasm of uterus required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 100% of hospital consultant episodes for benign neoplasm of uterus were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 4% of hospital consultant episodes for benign neoplasm of uterus required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 4.1 days was the mean length of stay in hospitals for benign neoplasm of uterus in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 4 days was the median length of stay in hospitals for benign neoplasm of uterus in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 48 was the mean age of patients hospitalised for benign neoplasm of uterus in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 84% of hospital consultant episodes for benign neoplasm of uterus occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 4% of hospital consultant episodes for benign neoplasm of uterus occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 49% of hospital consultant episodes for benign neoplasm of uterus were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.003% (1,795) of hospital bed days were for benign neoplasm of uterus in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)

About statistics:

This page presents a variety of statistics about Uterine Cancer. The term 'prevalence' of Uterine Cancer usually refers to the estimated population of people who are managing Uterine Cancer at any given time. The term 'incidence' of Uterine Cancer refers to the annual diagnosis rate, or the number of new cases of Uterine Cancer diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.



Footnotes: 1. SEER Cancer Statistics Review 1975-2000, National Cancer Institute (NCI)

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise